C-C motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells

ConclusionsCCL16 could be a feasible plasma marker to predict the occurrence and progression of liver cirrhosis. CCL16 might impact liver cirrhosis through inactivating hepatic stellate cells.
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research